Recent studies found that C21ORF2 V58L mutation in motor neurons induced from mouse embryonic stem cells impaired neurite outgrowth, suggesting the inhibition of NEK1 activity to be a potential therapeutic approach for ALS associated with C21ORF2 mutation (Watanabe et al., 2020). The gene discussed is NEK1; the disease is amyotrophic lateral sclerosis.